Clinical Trial: Efficacy and Safety of Ruxolitinib Phosphate Cream in Patients with Non-Segmental Vitiligo Refractory to Conventional Treatments: A Multicenter, Observational, Real-World Study (China)

Posted On: 2026-11-03

China, Nov. 3 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Efficacy and Safety of Ruxolitinib Phosphate Cream in Patients with Non-Segmental Vitiligo Refractory to Conventional Treatments: A Multicenter, Observational, Real-World Study'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600135777

Registration Time: 2026/11/02

Type: Observational study

Primary Sponsor: Dematology Hospital of Southern Medical University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=347623

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

इस लेख के रीप्रिंट को खरीदने या इस प्रकाशन का पूरा फ़ीड प्राप्त करने के लिए, कृपया हमे संपर्क करें.

विशेष

Category

Source

Publication

Location

Clinical Trial: Efficacy and Safety of Ruxolitinib Phosphate Cream in Patients with Non-Segmental Vitiligo Refractory to Conventional Treatments: A Multicenter, Observational, Real-World Study (China)